Dejun Ding
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Geriatrics and Gerontology top 5%
Papers in
-
- Advanced Drug Delivery Systems 4
-
- Free Radicals and Antioxidants 5
- Co-authors
- Weifen Zhang (17 shared papers)Wentong Li (14 shared papers)Chengcheng Gai (6 shared papers)Jie Zheng (2 shared papers)Mengyu Yu (2 shared papers)Shijun Lv (2 shared papers)Ni Cheng (8 shared papers)Weifen Zhang (5 shared papers)
- Journals
- Free Radical Biology and Medicine (3 papers)International Journal of Biological Macromolecules (3 papers)Frontiers in Pharmacology (3 papers)Chemistry - A European Journal (2 papers)Nanoscale Research Letters (2 papers)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Dejun Ding
38 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 108
- Cancer Research 382
- Geriatrics and Gerontology 66
- Biomaterials 248
- Pulmonary and Respiratory Medicine 488
- Pharmaceutical Science 99
Countries citing papers authored by Dejun Ding
This map shows the geographic impact of Dejun Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dejun Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dejun Ding more than expected).
Fields of papers citing papers by Dejun Ding
This network shows the impact of papers produced by Dejun Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dejun Ding. The network helps show where Dejun Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Dejun Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 304 | |
| 2 | 2017 | 139 | |
| 3 | 2019 | 133 | |
| 4 | 2018 | 103 | |
| 5 | 2020 | 87 | |
| 6 | 2022 | 77 | |
| 7 | 2015 | 74 | |
| 8 | 2017 | 69 | |
| 9 | 2018 | 69 | |
| 10 | 2018 | 64 | |
| 11 | 2018 | 62 | |
| 12 | 2016 | 62 | |
| 13 | 2021 | 60 | |
| 14 | 2020 | 54 | |
| 15 | 2013 | 51 | |
| 16 | 2022 | 49 | |
| 17 | 2011 | 46 | |
| 18 | 2023 | 45 | |
| 19 | 2021 | 42 | |
| 20 | 2021 | 36 |
About Dejun Ding
Dejun Ding is a scholar working on Pharmaceutical Science, Organic Chemistry, Biomaterials, Pulmonary and Respiratory Medicine and Rehabilitation, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Free Radicals and Antioxidants (5 papers), Ferroptosis and cancer prognosis (5 papers), Electrospun Nanofibers in Biomedical Applications (4 papers), Wound Healing and Treatments (4 papers), Advanced Drug Delivery Systems (4 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Advanced Nanomaterials in Catalysis (3 papers). The work is most often cited by research in Cancer Research (382 citations), Geriatrics and Gerontology (66 citations), Biomaterials (248 citations), Pulmonary and Respiratory Medicine (488 citations) and Pharmaceutical Science (99 citations). Dejun Ding has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Weifen Zhang, Wentong Li, Chengcheng Gai, Jie Zheng, Mengyu Yu, Shijun Lv, Ni Cheng, Weifen Zhang, Michael Keidar and Fang Dai. Their work appears in journals such as Free Radical Biology and Medicine, International Journal of Biological Macromolecules, Frontiers in Pharmacology, Chemistry - A European Journal and Nanoscale Research Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.